Medcura Closes $22.4 Million Financing to Accelerate Development of Surgical Hemostatic Gel and Surgical Hemostasis Portfolio ...Middle East

RIVERDALE, Md., April 3, 2024 /PRNewswire/ -- Medcura, Inc., a developer of hemostatic products for use in surgery, today announced that it has closed a private placement with aggregate gross proceeds of US $22.4 million (the "Offering") in Convertible Debt. The Company intends to use the...

Hence then, the article about medcura closes 22 4 million financing to accelerate development of surgical hemostatic gel and surgical hemostasis portfolio was published today ( Wednesday 03/04/2024 - 03:17 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Medcura Closes $22.4 Million Financing to Accelerate Development of Surgical Hemostatic Gel and Surgical Hemostasis Portfolio )

Also on site :

• AGIBOT's Humanoid Robots Take Home Multiple Best of CES 2026 Awards Following U.S. Debut
• INCHEON-IFEZ Booth Wraps Up a Successful CES 2026, Recording $560M in Export Consultations and 17 Innovation Awards
• Low Oil Prices Force Billionaire Harold Hamm to Halt Bakken Drilling